<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04201249</url>
  </required_header>
  <id_info>
    <org_study_id>MILES</org_study_id>
    <nct_id>NCT04201249</nct_id>
  </id_info>
  <brief_title>Mesotherapy In Lateral Epicondylitis</brief_title>
  <acronym>MILES</acronym>
  <official_title>MILES STUDY - Mesotherapy In Lateral Epicondylitis, a Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Santa Maria, Portugal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Santa Maria, Portugal</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigate the short- and long-term efficacy and safety of intradermal NSAIDs and lidocaine
      (delivered through mesotherapy) for the treatment of LE comparing it with empty intradermal
      injections.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">December 12, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 12, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity: visual analogue scale score</measure>
    <time_frame>3 months</time_frame>
    <description>pain intensity quantified by using a 0-100 visual analogue scale (VAS) score; a higher score means a higher pain intensity on the VAS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical and functional evaluation</measure>
    <time_frame>0, 1, 2, 3 weeks and 6 months</time_frame>
    <description>American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES-E) score, ranging from 0 to 5 in strenght assessment (0=no contraction; 1=flicker; 2=movement with gravity eliminated; 3=movement against gravity; 4=movement with some resistance; 5=normal power) and from 0-3 in the stability section (0=no instability; 1=mild laxity with good endpoint; 2=moderate laxity no endpoint;3=gross instability)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Lateral Epicondylitis</condition>
  <arm_group>
    <arm_group_label>Mesotherapy with piroxicam and lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mesotherapy without piroxicam and lidocaine</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Piroxicam, lidocaine</intervention_name>
    <description>Patients will be randomized to 2 groups group A - mesotherapy with piroxicam (20mg/ml, 1ml) and lidocaine (1%, 1.5ml) (treatment arm); group group B - mesotherapy without piroxicam</description>
    <arm_group_label>Mesotherapy with piroxicam and lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mesotherapy without drug administration</intervention_name>
    <description>Patients will be randomized to 2 groups group A - mesotherapy with piroxicam (20mg/ml, 1ml) and lidocaine (1%, 1.5ml) (treatment arm); group group B - mesotherapy without piroxicam</description>
    <arm_group_label>Mesotherapy without piroxicam and lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis defined as pain over the lateral epicondyle provoked by palpation;

          -  A visual analogue scale (VAS) score for pain greater than 40mm;

          -  symptoms duration for more than 1 month.

        Exclusion Criteria:

          -  other diseases that can alter clinical evaluation detected through history, clinical
             examination, ultrasound or other exams for comorbidities such as carpal tunnel
             syndrome, cervical radiculopathy, elbow arthritis, intra-articular loose bodies,
             previous elbow surgery or clinically significant or recent trauma, fibromyalgia and
             major psychiatric conditions;

          -  VAS score for pain less than 40mm;

          -  any of the following treatments during the previous 4 weeks before baseline visit:
             physical therapy, bandage, mesotherapy and local corticosteroid injection or a
             combination of these: NSAIDS taken during the week previous to inclusion;

          -  pregnancy;

          -  allergy to any of the study drugs;

          -  severely immunosuppressed patients;

          -  known coagulopathies. During the study period, enrolled patients are not allowed to
             take oral corticosteroids, NSAIDs or receive any other medical intervention during the
             treatment period (physical therapy, bandage, mesotherapy and local corticosteroid
             injection or a combination of these).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vitor AS Teixeira</last_name>
    <phone>918219891</phone>
    <phone_ext>00351</phone_ext>
    <email>vitor.as.teixeira@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vítor AS Teixeira</last_name>
      <phone>918219891</phone>
      <phone_ext>00351</phone_ext>
      <email>vitor.as.teixeira@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 11, 2019</study_first_submitted>
  <study_first_submitted_qc>December 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2019</study_first_posted>
  <last_update_submitted>December 16, 2019</last_update_submitted>
  <last_update_submitted_qc>December 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Santa Maria, Portugal</investigator_affiliation>
    <investigator_full_name>Vítor Teixeira</investigator_full_name>
    <investigator_title>Vitor Teixeira</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Piroxicam</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

